Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Cubero

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Gut|September 12, 2024
Identification of PRMT5 as a therapeutic target in cholangiocarcinomaJasmin Elurbide, Leticia Colyn, Maria U Latasa, et al.
Cell Metabolism|February 24, 2026
Lack of PCK1 in hepatic stellate cells causes liver fibrosis by fueling tricarboxylic acid cycle and increasing glycolysisEva Novoa, Tamara Parracho, Julica Inderhees, et al.
Cancers|June 25, 2020
Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning ApproachJesús M Urman, José M Herranz, Iker Uriarte, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 26, 2022
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogrammingLeticia Colyn, Gloria Alvarez-Sola, M Ujue Latasa, et al.
Hepatology (Baltimore, Md.)|November 22, 2020
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental CholangiocarcinomaLeticia Colyn, Marina Bárcena-Varela, Gloria Álvarez-Sola, et al.
Gut Microbes|February 21, 2026
Alcohol consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): understanding the gut-liver crosstalk for clinical translationRaquel Benedé-Ubieto, Olga Estévez-Vázquez, Rana Acar, et al.
Cell Death & Disease|August 10, 2023
Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosisKang Zheng, Fengjie Hao, Sandra Medrano-Garcia, et al.
Gastroenterologia Y Hepatologia|May 9, 2024
Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)Edilmar Alvarado-Tapias, Douglas Maya-Miles, Agustin Albillos, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2024
Loss of <i>Cdkn1a</i> protects against MASLD alone or with alcohol intake by preserving lipid homeostasisArantza Lamas-Paz, Alejandro Hionides-Gutiérrez, Feifei Guo, et al.
Gut|August 5, 2025
Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potentialMaria Mercado-Gómez, Naroa Goikoetxea-Usandizaga, Alvaro Eguileor Giné, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Gut|September 12, 2024
Identification of PRMT5 as a therapeutic target in cholangiocarcinomaJasmin Elurbide, Leticia Colyn, Maria U Latasa, et al.
Cell Metabolism|February 24, 2026
Lack of PCK1 in hepatic stellate cells causes liver fibrosis by fueling tricarboxylic acid cycle and increasing glycolysisEva Novoa, Tamara Parracho, Julica Inderhees, et al.
Cancers|June 25, 2020
Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning ApproachJesús M Urman, José M Herranz, Iker Uriarte, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 26, 2022
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogrammingLeticia Colyn, Gloria Alvarez-Sola, M Ujue Latasa, et al.
Hepatology (Baltimore, Md.)|November 22, 2020
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental CholangiocarcinomaLeticia Colyn, Marina Bárcena-Varela, Gloria Álvarez-Sola, et al.
Gut Microbes|February 21, 2026
Alcohol consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): understanding the gut-liver crosstalk for clinical translationRaquel Benedé-Ubieto, Olga Estévez-Vázquez, Rana Acar, et al.
Cell Death & Disease|August 10, 2023
Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosisKang Zheng, Fengjie Hao, Sandra Medrano-Garcia, et al.
Gastroenterologia Y Hepatologia|May 9, 2024
Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)Edilmar Alvarado-Tapias, Douglas Maya-Miles, Agustin Albillos, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2024
Loss of <i>Cdkn1a</i> protects against MASLD alone or with alcohol intake by preserving lipid homeostasisArantza Lamas-Paz, Alejandro Hionides-Gutiérrez, Feifei Guo, et al.
Gut|August 5, 2025
Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potentialMaria Mercado-Gómez, Naroa Goikoetxea-Usandizaga, Alvaro Eguileor Giné, et al.
Pageof 12